The functional significance of the TGM2 gene in schizophrenia: A correlation of SNPs and circulating IL-2 levels

Journal of Neuroimmunology

Volumn 232, Issue 1-2, 2011, Pages 5-7

  Bradford, Matilda ^a   Law, Matthew H ^a   Megson, Ian L ^a   Wei, Jun ^a  

^a UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

Author keywords

Interleukin 2 (IL 2); Schizophrenia; TGM2 gene; Tissue transglutaminase

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; INTERLEUKIN 2; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA EXTRACTION; FEMALE; GENE; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TGM2 GENE;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-2; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; TRANSGLUTAMINASES;

EID: 79952244515     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.09.007     Document Type: Article

References (21)

1. Bessler H., Levental Z., Karp L., Modai I., Djaldetti M., Weizman A. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients. Biol. Psychiatry 1995, 38:297-302.
2. Boscolo S., Sarich A., Lorenzon A., Passoni M., Rui V., Stebel M., Sblattero D., Marzari R., Hadjivassiliou M., Tongiorgi E. Gluten ataxia-passive transfer in a mouse model. Ann. N.Y. Acad. Sci. 2007, 1107:319-328.
3. Bradford M., Law M.H., Stewart A.D., Shaw D.J., Megson I.L., Wei J. The TGM2 gene is associated with schizophrenia in a British population. Am. J. Med. Genet. 2009, 150B:335-340.
4. Bruce L.C., Peebles A.M.S. Clinical and experimental observations on catatonia. J. Ment. Sci. 1903, 49:614-628.
5. Cascella N.G., Kryszak D., Bhatti B., Gregory P., Kelly D.L., McEvoy J.P., Fasano A., Eaton W.W. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr. Bull. 2009, (Epub ahead of print).
6. De Santis A., Addolorato G., Romito A., Caputo S., Giordano A., Gambassi G., Taranto C., Manna R., Gasbarrini G. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J. Intern. Med. 1997, 242:421-423.
7. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Leister F., Yang S., Krivogorsky B., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol. Psychiatry 2010, 68:100-104.
8. Eaton W.W., Mortensen P.B., Agerbo E., Byrne M., Mors O., Ewald H. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. Br. Med. J. 2004, 328:438-439.
9. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., Mortensen P.B. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 2006, 163:521-528.
10. Falcone T., Carlton E., Batra A., Franco K., Simon B., Janigro D. Monocytosis in a group of children with first episode psychosis. Schizophr. Res. 2008, 98. (Suppl): 140 (Abstract).
11. Ganguli R., Rabin B.S., Belle S.H. Decreased interleukin-2 production in schizophrenic patients. Biol. Psychiatry 1989, 26:427-430.
12. Jin S.-Z., Xu Q., Wu N., Zhang X., Liu S.-Z., Shen Y., Law M.H., Wei J. A study of gluten antibody levels in serum among patients with schizophrenia. Schizophr. Res. 2008, 98:145. (Meeting abstract).
13. Na K.S., Kim Y.K. Monocytic, Th1 and Th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology 2007, 56:55-63.
14. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 2008, 63:801-808.
15. Reichelt K.L., Landmark J. Specific IgA antibody increases in schizophrenia. Biol. Psychiatry 1995, 37:410-413.
16. The International Schizophrenia Consortium Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
17. Villemain F., Chatenoud L., Guillibert E., Pelicier Y., Bach J.F. Decreased production of interleukin-2 in schizophrenia. Ann. N.Y. Acad. Sci. 1987, 469:669-675.
18. Wei J., Ramchand C.N., Hemmings G.P. Studies on concentrations of NA and HVA and activity of DBH in the serum from schizophrenic patients, first-degree relatives and normal subjects. Schizophr. Res. 1992, 8:103-110.
19. Wilke I., Arolt V., Hornberg M., Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenics. Eur. Arch. Psychiatry Clin. Neurosci. 1996, 246:279-284.
20. Xu H.-M., Wei J., Hemmings G.P. Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia. Br. J. Psychiatry 1994, 164:251-253.
21. Zorrilla E., Cannon T., Kessler J., Gur R. Leukocyte differentials predict short-term clinical outcome following antipsychotic treatment in schizophrenia. Biol. Psychiatry 1998, 12:887-896.